arrow
J

Jonathan D. Powell

Johns Hopkins University
H指数:72
被引数:2.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Retraction Note: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer

撤稿说明:经过重新设计的BCG过量表达环二腺苷酸,增强了训练性免疫,并显示出对膀胱癌的改进效果。

2026-03-230
OAAI
Distinct myeloid-derived suppressor cell populations in human glioblastoma

人类胶质母细胞瘤中不同的髓源性抑制细胞群

Science
IF45.8
2025-01-010
OAAI
Glutamine antagonist prodrug JHU083 reprograms immunosuppressive tumor-associated macrophages to drive tumor immunity in urologic cancers
2023-06-020
PRE
First-in-human phase 1 studies of PTPN2/1 inhibitors ABBV-CLS-484 and ABBV-CLS-579 in locally advanced or metastatic tumors
2023-04-143
PRE
Glutamine antagonist prodrug JHU083 reprograms immunosuppressive tumor-associated macrophages (TAMs) to drive tumor immunity in urologic cancers
2023-04-041
PRE
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug

肿瘤靶向代谢抑制剂前药DRP-104的发现

2022-11-1652
OAAI
Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses
2021-05-1761
OA
Antigen-driven EGR2 expression is required for exhausted CD8+ T cell stability and maintenance

抗原驱动的EGR2表达是耗尽CD8 T细胞稳定性和维持所必需的

2021-05-1327
OAAI